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Background: The Gamma-aminobutyric acid type A receptor (GABA-A receptor) is
affected by ethanol concentrations equivalent to those reached during social drinking.
At these concentrations, ethanol usually causes impairment in reaction and motor times
in most, but not all, individuals.
Objectives: To study the effect of GABA-A receptor variability in motor and reaction
times, and the effect of low ethanol doses.
Methods: Two hundred and fifty healthy subjects received one single dose of 0.5 g/Kg
ethanol per os. Reaction and motor times were determined before ethanol challenge
(basal), and when participants reached peak ethanol concentrations. We analyzed all
common missense polymorphisms described in the 19 genes coding for the GABA-A
receptor subunits by using TaqMan probes.
Results: The GABRA6 rs4454083 T/C polymorphisms were related to motor times,
with individuals carrying the C/C genotype having faster motor times, both, at basal
and at peak ethanol concentrations. The GABRA4 rs2229940 T/T genotype was
associated to faster reaction times and with lower ethanol effects, determined as
the difference between basal reaction time and reaction time at peak concentrations.
All these associations remained significant after correction for multiple comparisons.
No significant associations were observed for the common missense SNPs GABRB3
rs12910925, GABRG2 rs211035, GABRE rs1139916, GABRP rs1063310, GABRQ
rs3810651, GABRR1 rs12200969 or rs1186902, GABRR2 rs282129, and GABRR3
rs832032.
Conclusions: This study provides novel information supporting a role of missense
GABA-A receptor polymorphisms in reaction time, motor time and effects of low ethanol
doses in vivo.
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INTRODUCTION
The Gamma-aminobutyric acid type A receptor (GABA-A
receptor) is a ligand-gated ion channel that plays a key role
in the inhibition of neurotransmission because, when activated
by GABA, it causes neuronal hyperpolarization. The activation
of the GABA-A receptor by ethanol has long been well-known
(Hunt, 1983; Kulonen, 1983; Leidenheimer and Harris, 1992;
Aguayo et al., 2002; Chester and Cunningham, 2002; Lobo and
Harris, 2008; Kumar et al., 2009b; Zuo et al., 2017), and it
is related to the motor effects of ethanol. Independent studies
have shown that ethanol exposure modulates neuronal function
by potentiating GABA-A effects, whereas ethanol effects are
blocked by GABA-A antagonists such as bicuculline, Ro15-
1788, or picrotoxin (Mehta and Ticku, 1988; Ticku, 1989, 1990;
Allan et al., 1991; Miczek et al., 1997). Moreover, GABA-A
antagonists seem to reduce ethanol self-administration (Chester
and Cunningham, 2002; Holtyn et al., 2017) and GABA system
has been proposed as a therapeutic target for alcoholism therapy
(Caputo and Bernardi, 2010; Liang and Olsen, 2014; Long et al.,
2017; Prisciandaro et al., 2017). In addition, chronic ethanol
exposure modifies the expression of some GABA-A receptors
subunits (Wallner et al., 2014; Wang et al., 2014; Bekdash and
Harrison, 2015; Ortiz et al., 2015; Bohnsack et al., 2016, 2017;
Carlson et al., 2016), thus suggesting the involvement of GABA-
A in ethanol tolerance and dependence (Mhatre and Ticku, 1993;
Grobin et al., 2000; Davies, 2003; Kumar et al., 2004; Blednov
et al., 2017; Caputo et al., 2017; Chandler et al., 2017; Lieberman
et al., 2017; Lindemeyer et al., 2017; McCabe et al., 2017).
Other effects induced by chronic ethanol exposure on GABA-
A are changes in receptor function, phosphorylation, synaptic
localization and changes in the receptor subunit composition
(Kumar et al., 2004; Follesa et al., 2006; Weiner and Valenzuela,
2006; Enoch, 2008).
Human GABA-A receptors are pentamers, composed of
a combination of 19 different subunits, namely, six GABRα
(GABRα1 to GABRα6), three GABRβ (GABRβ1 to GABRβ3),
three GABRγ (GABRγ1 to GABRγ3), one each of GABRδ,
GABRε, GABRπ and GABRθ (GABRQ) and three GABRρ
(GABRρ1 to GABRρ3). The major isoform consists of α1, β2, and
γ2 subunits, but many other combinations exist, and it is widely
accepted that the subunit combination plays a key role in the
function of these receptors (Olsen and Sieghart, 2008, 2009; Sigel
and Steinmann, 2012; Martenson et al., 2017). Some subunits
and some combinations seem to be more sensitive to ethanol
effects than others. It has been shown that highest sensitivity to
ethanol is observed with the combination GABRα4 + GABRβ3
+ GABRδ and GABRα6 + GABRβ3 + GABRδ (Hanchar et al.,
2004). Receptors with such particular subunit combinations are
affected by low ethanol concentrations (Wallner et al., 2006;
Lovinger and Homanics, 2007), although these findings are not
free of controversy (Borghese and Harris, 2007; Botta et al., 2007;
Jia et al., 2007; Korpi et al., 2007; Mody et al., 2007; Olsen et al.,
2007; Santhakumar et al., 2007).
The response to ethanol in vivo is very variable and many
factors, besides variability in ethanol metabolism, modify ethanol
response. Sex differences in the sensitivity of GABA-A receptors
have been shown (Finn et al., 2010) but, interestingly, it has
been reported that most of the interindividual variability in the
response to ethanol depends on inheritance (Matsushita and
Higuchi, 2014). This suggest that genetic variations may play a
relevant role in ethanol effects.
In animal models, alteration in the response to ethanol has
been related to amino-acid changes in some GABA-A receptor
subunits (Loh and Ball, 2000), and it has been suggested that
inter- individual variability in the motor impairment caused by
low doses of ethanol are related to genetic variability in genes
coding for GABA-A receptor subunits (Korpi, 1994; Wallner
et al., 2006). For instance, in animal models, a mutation in the
GABRα6 subunit has been associated with motor impairment
and ethanol sensitivity (Wallner et al., 2006). Information about
the putative role of GABA-A genetic variations in ethanol effects
in humans, however, is scarce.
The 19 human genes coding for GABA-A receptor subunits
contain several common missense polymorphisms (Table 1).
Some of the amino acid substitutions have been classified as
deleterious according to Sorting Intolerant From Tolerant (SIFT)
(Kumar et al., 2009a) and/or Polymorphism Phenotyping v2
(PolyPhen-2) prediction (Adzhubei et al., 2010). In a previous
study we observed that a relevant percentage of the population,
when exposed to low ethanol doses, did not diminish their
reaction time and motor time, but rather were not significantly
affected or it even improved their performance (Martinez et al.,
2010). The reason for this dimorphism in the response to
ethanol is unknown, although we demonstrated that it is not
related to ethanol pharmacokinetics (Martinez et al., 2010). This
raises the question of whether pharmacodynamicmechanisms, or
genetic predisposition, may be involved in such inter-individual
variability to ethanol response. In this study, we investigated
whether common missense GABR polymorphisms are modifiers
of response to low doses of ethanol in vivo, with the focus on
effects on motor and reaction times.
METHODS
This study was performed on a group of individuals involved
in a previous study on the effect of variability of genes coding
for ethanol-metabolizing enzymes in ethanol pharmacokinetics
and effects (Martinez et al., 2010). The study group consisted
of 250 healthy individuals (66 men and 184 women), with a
mean age equal to 22.5 ± 6.2 years. All were Spanish Caucasian
individuals recruited at the Medical School of the University of
Extremadura (Badajoz, Spain) among students and staff. The
inclusion criteria included absence of ethanol consumption,
absence of consumption of drugs with known effects in the
nervous system, as well as illicit drugs 7 days before the study.
We recorded data on age, sex, smoking, and drinking habits.
Signed informed consent was obtained for all participants. The
protocol of the study was approved by the Ethics Committee of
the University Hospital Infanta Cristina (Badajoz, Spain).
Ethanol Challenge and Determination of
Ethanol Effects
The design of ethanol challenge and the pharmacokinetic
analysis is described elsewhere (Martinez et al., 2010). In
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TABLE 1 | Common stop and missense SNPs in GABR genes and allele frequencies according the 1,000 genomes database.
Gene Chromosomal location Missense SNPs with minor allele









GABRA1 Chromosome 5: 161,274,197–161,326,975 None – – – –
GABRA2 Chromosome 4: 46,250,444–46,477,247 None – – – –
GABRA3 Chromosome X: 151,334,706–151,619,830 None – – – –
GABRA4 Chromosome 4: 46,920,917–46,996,424 rs2229940 0.301 0.370 M26L C__22274760_10
GABRA5 Chromosome 15: 27,111,510–27,194,354 None – – – –
GABRA6 Chromosome 5: 160,974,069–161,129,599 rs4454083 0.262 0.300 L13P C____220485_10
GABRB1 Chromosome 4: 46,995,740–47,428,461 None – – – –
GABRB2 Chromosome 5: 160,715,436–160,976,050 None – – – –
GABRB3 Chromosome 15: 26,788,693–27,184,686 rs17647384 0.338 0.460 R23C –a
GABRB3 Chromosome 15: 26,788,693–27,184,686 rs12910925 0.338 0.460 R50W C__11753146_10
GABRG1 Chromosome 4: 46,037,786–46,126,098 None – – – –
GABRG2 Chromosome 5: 161,494,546–161,582,542 rs211035 0.179 0.200 I215V C__26181781_10
GABRG3 Chromosome 15: 27,216,429–27,778,373 None – – – –
GABRD Chromosome 1: 1,950,780–1,962,192 None – – – –
GABRE Chromosome X: 151,121,596–151,143,152 rs1139916 0.294 0.300 S102A C__15868735_20
GABRP Chromosome 5: 170,190,354–170,241,051 rs1063310 0.224 0.260 F391L C___8953491_20
GABRQ Chromosome X: 151,806,637–151,825,999 rs3810651 0.435 0.440 I478F C__27492635_10
GABRR1 Chromosome 6: 89,887,220–89,940,997 rs12200969 0.306 0.350 M26V C__11420642_10
GABRR1 Chromosome 6: 89,887,220–89,940,997 rs1186902 0.231 0.260 H27R C___8945590_20
GABRR2 Chromosome 6: 89,966,927–90,025,018 rs282129 0.252 0.250 T430M C___2332356_20
GABRR3 Chromosome 3: 97,705,517–97,754,148 rs832032 0.173 0.190 Y205Stop C___8751472_10
aThis SNP was not tested because it is at complete linkage with another common SNP (rs12910925) located in the same gene.
brief, participants started the challenge at the same hour, after
overnight fasting. Participants received 0.5 g/Kg ethanol per os as
liquor containing 17% ethanol. In order to determine when the
peak concentration was reached, breath samples were measured
every 15min by using a breath analyzer Alcotest-7710 (Dräger
Safety, Spain). Pharmacokinetic determinations were carried out
until ethanol levels reached values lower than 0.02 g/L in air, or
during 5 h.
After training, participants carried out tests designed to
determine reaction time and motor time by using the Vienna
Test System 5.20 (Dr. G. Schuhfried GMBH 2003, Austria). Each
participant carried out one test just before the ethanol challenge
and then one test every 30min. Each time, 16 measurements of
reaction time and motor time were carried out, and the average
values for these determinations were used for further analyses.
Test takers had their finger on a gold button, moving it to press
a black button when they perceived a determined visual stimuli.
Reaction time is defined as the time lapsed between displaying
the stimulus and removing the finger from the gold button, and
motor time is defined as the time lapsed between removing the
finger from the gold button until the black button is pressed. To
assess ethanol effect on the reaction times and in the motor times,
we compared these parameters at basal conditions (the average
of the results before ethanol administration and after ethanol
concentration in breath were lower than 0.05 g/L) with those
obtained at peak ethanol concentration.
Genotyping
Genomic DNA was obtained from venous blood as described
elsewhere. The selection of the non-synonymous GABRR
polymorphisms analyzed was made according to the expected
allele frequencies in the population study previously reported in
public databases such as the public 1,000 genomes database1 The
study was designed to investigate all non-synonymous and/or
nonsense SNPs with minor allele frequencies (MAF) higher than
0.1 for individuals of European descent, for the 19 GABA-
A receptor genes described in Table 1. SNPs with lower MAF
were not included in the study because the statistical power
would be insufficient to obtain conclusive evidence. According
to the 1,000 genomes database, 12 SNPs fulfilled the selection
criteria. However, two GABRB3 SNPs, namely rs12910925 and
rs17647384, are at complete linkage, and therefore only the
former was included in the study. Genotyping was carried out
in triplicate using SNP TaqMan assays (Life Technologies S.A.,
Alcobendas, Madrid, Spain). Further details on Assay ID are
provided in Table 1.
Statistical Analyses
Statistical analyses were carried out by using the IBM SPSS
Statistical Package Version 22 (International Business Machines
Corporation,Madrid, Spain). Intergroup comparison values were
1http://phase3browser.1000genomes.org/Homo_sapiens/Info/Index.
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 January 2018 | Volume 12 | Article 10
García-Martín et al. Effect of GABRA-A Gene Variations
calculated by using the T-test when appropriate. After normality
test, multiple comparison of means was carried out by using
the Kruskal–Wallis test for independent samples, because most
parameters did not follow a normal distribution. Multiple testing
correction was carried out by means of the False Discovery Rate
(FDR) procedure (Benjamini and Hochberg, 1995). Haplotypes
were calculated as described elsewhere (Mateos-Munoz et al.,
2016). The Hardy–Weinberg equilibrium was analyzed through
the DeFinetti procedure (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl).
RESULTS
GABRA genotyping results stratified by sex are summarized in
Table 2. The genotypes and allele frequencies observed for the
SNP analyzed are consistent with those reported elsewhere for
healthy Spanish individuals (Garcia-Martin et al., 2011a,b, 2017)
and with those reported in public databases2 All SNPs were at
Hardy-Weinberg’s equilibrium with the exception of the SNPs
GABRE rs1139916 and GABRQ rs3810651, which correspond
to genes located in the X chromosome (as shown in Table 1).
These two SNPswere at Hardy-Weinberg’s equilibrium inwomen
(Pearson’s goodness-of-fit chi-square P = 0.361 and P = 0.707,
respectively), but not in men, as is to be expected in genes located
on chromosome X.
The ethanol challenge was designed to obtain low peak
concentrations, comparable to the ethanol concentrations
reached during social drinking, that is, between two and four
drinks depending on body weight (one drink being equal to 14 g
of pure ethanol). In the population studied, peak concentrations
in breath ranged from 0.19 to 0.65 g/L (average 0.42 ± 0.09 g/L)
and peak concentrations were reached in the range 15 to 90min
after ethanol ingestion (mean 37.0 ± 16.8min). We described
previously in this study group that no statistically significant
associations of reaction or motor times with peak concentration
or drinking habits were observed, but average motor values, both,
basal, and peak motor times, were shorter in men than in women
(Martinez et al., 2010), and the statistical association remained
significant after FDR correction for multiple testing (Pc = 0.030
for basal motor time and Pc = 0.012 for peak motor time).
The finding that motor times are faster in men than in women
was reported previously in another study involving different
participants (Jimenez-Jimenez et al., 2011).
In order to test the putative effect of the GABR genotypes
analyzed on reaction and motor times, we stratified the
population according to the 11 SNPs studied. Table 3 shows the
distribution of the reaction times according to GABR genotypes.
Basal reaction time, peak reaction time, and the difference
(peak time minus basal time) were shorter among individuals
carrying the GABRA4 rs2229940 T/T genotype, as compared
to individuals carrying at least one non-mutated gene. The
K–W test remains significant for peak reaction time and the
difference (peak time minus basal time), even after correction for
multiple comparison. In addition, the T-test revealed significant
differences when comparing individuals with the rs2229940 T/T
genotype with individuals carrying at least one non-mutated
2http://phase3browser.1000genomes.org/Homo_sapiens/Info/Index.
TABLE 2 | GABR genotypes and allele frequencies distributed by sex.
Genotypes Women (No; 95% CI) Men (No; 95% CI)
GABRA4 rs2229940 G/G 73 (38.6; 31.7 to 45.6) 26 (42.6; 30.2 to 55.0)
GABRA4 rs2229940 G/T 87 (46.0; 38.9 to 53.1) 23 (37.7; 25.5 to 49.9)
GABRA4 rs2229940 T/T 29 (15.3; 10.2 to 20.5) 12 (19.7; 9.7 to 29.6)
GABRA6 rs4454083 T/T 99 (52.4; 45.3 to 59.5) 29 (47.5; 35.0 to 60.1)
GABRA6 rs4454083 T/C 66 (34.9; 28.1 to 41.7) 26 (42.6; 30.2 to 55.0)
GABRA6 rs4454083 C/C 24 (12.7; 8.0 to 17.4) 6 (9.8; 2.4 to 17.3)
GABRB3 rs12910925 C/C 54 (28.6; 22.1 to 35.0) 17 (27.9; 16.6 to 39.1)
GABRB3 rs12910925 C/T 96 (50.8; 43.7 to 57.9) 29 (47.5; 35.0 to 60.1)
GABRB3 rs12910925 T/T 39 (20.6; 14.9 to 26.4) 15 (24.6; 13.8 to 35.4)
GABRG2 rs211035 G/G 133 (70.4; 63.9 to 76.9) 40 (65.6; 53.7 to 77.5)
GABRG2 rs211035 G/A 54 (28.6; 22.1 to 35.0) 21 (34.4; 22.5 to 46.3)
GABRG2 rs211035 A/A 2 (1.1; −0.4 to 2.5) 0 (0.0; 0.0 to 0.0)
GABRE rs1139916 C/C 76 (40.2; 33.2 to 47.2) 43 (70.5; 59.0 to 81.9)
GABRE rs1139916 C/A 83 (43.9; 36.8 to 51.0) –
GABRE rs1139916 A/A 30 (15.9; 10.7 to 21.1) 18 (29.5; 18.1 to 41.0)
GABRP rs1063310 C/C 112 (59.3; 52.3 to 66.3) 38 (62.3; 50.1 to 74.5)
GABRP rs1063310 C/A 67 (35.4; 28.6 to 42.3) 21 (34.4; 22.5 to 46.3)
GABRP rs1063310 A/A 10 (5.3; 2.1 to 8.5) 2 (3.3; −1.2 to 7.7)
GABRQ rs3810651 T/T 70 (37.0; 30.2 to 43.9) 35 (57.4; 45.0 to 69.8)
GABRQ rs3810651 T/A 88 (46.6; 39.4 to 53.7) –
GABRQ rs3810651 A/A 31 (16.4; 11.1 to 21.7) 26 (42.6; 30.2 to 55.0)
GABRR1 rs12200969 T/T 99 (52.4; 45.3 to 59.5) 35 (57.4; 45.0 to 69.8)
GABRR1 rs12200969 T/C 69 (36.5; 29.6 to 43.4) 21 (34.4; 22.5 to 46.3)
GABRR1 rs12200969 C/C 21 (11.1; 6.6 to 15.6) 5 (8.2; 1.3 to 15.1)
GABRR1 rs1186902 T/T 172 (91.0; 86.9 to 95.1) 54 (88.5; 80.5 to 96.5)
GABRR1 rs1186902 T/C 17 (9.0; 4.9 to 13.1) 7 (11.5; 3.5 to 19.5)
GABRR1 rs1186902 C/C 0 (0.0; 0.0 to 0.0) 0 (0.0; 0.0 to 0.0)
GABRR2 rs282129 G/G 126 (66.7; 59.9 to 73.4) 39 (63.9; 51.9 to 76.0)
GABRR2 rs282129 G/A 55 (29.1; 22.6 to 35.6) 21 (34.4; 22.5 to 46.3)
GABRR2 rs282129 A/A 8 (4.2; 1.4 to 7.1) 1 (1.6; −1.5 to 4.8)
GABRR3 rs832032 A/A 115 (60.8; 53.9 to 67.8) 39 (63.9; 51.9 to 76.0)
GABRR3 rs832032 A/T 66 (34.9; 28.1 to 41.7) 20 (32.8; 21.0 to 44.6)
GABRR3 rs832032 T/T 8 (4.2; 1.4 to 7.1) 2 (3.3; −1.2 to 7.7)
Alleles Women (No; 95% CI) Men (No; 95% CI)
GABRA4 rs2229940G 233 (61.6; 56.7 to 66.5) 75 (61.5; 52.8 to 70.1)
GABRA4 rs2229940T 145 (38.4; 33.5 to 43.3) 47 (38.5; 29.9 to 47.2)
GABRA6 rs4454083T 264 (69.8; 65.2 to 74.5) 84 (68.9; 60.6 to 77.1)
GABRA6 rs4454083C 114 (30.2; 25.5 to 34.8) 38 (31.1; 22.9 to 39.4)
GABRB3 rs12910925C 204 (54.0; 48.9 to 59.0) 63 (51.6; 42.8 to 60.5)
GABRB3 rs12910925T 174 (46.0; 41.0 to 51.1) 59 (48.4; 39.5 to 57.2)
GABRG2 rs211035G 320 (84.7; 81.0 to 88.3) 101 (82.8; 76.1 to 89.5)
GABRG2 rs211035A 58 (15.3; 11.7 to 19.0) 21 (17.2; 10.5 to 23.9)
GABRE rs1139916C 235 (62.2; 57.3 to 67.1) 43 (70.5; 59.0 to 81.9)
GABRE rs1139916A 143 (37.8; 32.9 to 42.7) 18 (29.5; 18.1 to 41.0)
GABRP rs1063310C 291 (77.0; 72.7 to 81.2) 97 (79.5; 72.3 to 86.7)
GABRP rs1063310A 87 (23.0; 18.8 to 27.3) 25 (20.5; 13.3 to 27.7)
GABRQ rs3810651T 228 (60.3; 55.4 to 65.2) 35 (57.4; 45.0 to 69.8)
GABRQ rs3810651A 150 (39.7; 34.8 to 44.6) 26 (42.6; 30.2 to 55.0)
GABRR1 rs12200969T 267 (70.6; 66.0 to 75.2) 91 (74.6; 66.9 to 82.3)
GABRR1 rs12200969C 111 (29.4; 24.8 to 34.0) 31 (25.4; 17.7 to 33.1)
GABRR1 rs1186902T 361 (95.5; 93.4 to 97.6) 115 (94.3; 90.1 to 98.4)
GABRR1 rs1186902C 17 (4.5; 2.4 to 6.6) 7 (5.7; 1.6 to 9.9)
GABRR2 rs282129G 307 (81.2; 77.3 to 85.2) 99 (81.1; 74.2 to 88.1)
GABRR2 rs282129A 71 (18.8; 14.8 to 22.7) 23 (18.9; 11.9 to 25.8)
GABRR3 rs832032A 296 (78.3; 74.2 to 82.5) 98 (80.3; 73.3 to 87.4)
GABRR3 rs832032T 82 (21.7; 17.5 to 25.8) 24 (19.7; 12.6 to 26.7)
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TABLE 3 | Distribution of reaction times according GABR genotypes.
Basal reaction time (Ms) ± SD Reaction time at ethanol Peak (Msec) ± SD Difference (Ms) ± SD
GABRA4 rs2229940 G/T G/G: 452.60 ± 88.63
G/T: 484.66 ± 89.46
T/T: 444.99 ± 58.39
K–W test, P =0.007; Pc = 0.077
G/G: 515.12 ± 93.31
G/T: 548.99 ± 98.63
T/T: 471.32 ± 71.91
K–W test, P = 0.001; Pc = 0.011
G/G: 62.51 ± 63.67
G/T: 64.33 ± 55.77
T/T: 26.32 ± 62.21
K–W test, P = 0.002; Pc = 0.022
GABRA6 rs4454083 T/C T/T: 465.11 ± 88.70
T/C: 468.15 ± 83.33
C/C: 441.25 ± 64.09
K–W test, P = 0.484; Pc = 0.591
T/T: 513.12 ± 95.32
T/C: 533.43 ± 101.35
C/C: 509.76 ± 65.54
K–W test, P = 0.417; Pc = 0.655
T/T: 48.00 ± 63.13
T/C: 65.28 ± 62.59
C/C: 68.51 ± 53.51
K–W test, P = 0.081; Pc = 0.223
GABRB3 rs12910925 C/T C/C: 463.55 ± 76.01
C/T: 464.92 ± 89.30
T/T: 466.97 ± 77.12
K–W test, P = 0.895; Pc = 0.967
C/C: 512.87 ± 86.59
C/T: 523.52 ± 97.35
T/T: 523.51 ± 99.92
K–W test, P = 0.832; Pc = 0.984
C/C: 49.32 ± 55.11
C/T: 58.61 ± 59.04
T/T: 56.55 ± 75.27
K–W test, P = 0.553; Pc = 0.676
GABRG2 rs211035 G/A G/G: 460.17 ± 85.86
G/A: 469.96 ± 78.56
A/A: 548.75 ± 61.16
K–W test, P = 0.227; Pc = 0.528
G/G: 516.81 ± 92.47
G/A: 529.31 ± 100.17
A/A: 503.50 ± 161.93
K–W test, P = 0.897; Pc = 0.984
G/G: 56.63 ± 58.82
G/A: 59.34 ± 66.65
A/A: 45.25 ± 100.76
K–W test, P = 0.210; Pc = 0.400
GABRE rs1139916 C/A C/C: 460.48 ± 95.58
C/A: 467.05 ± 78.86
A/A: 477.62 ± 79.80
K–W test, P = 0.355; Pc = 0.542
C/C: 523.94 ± 103.39
C/A: 525.22 ± 100.02
A/A: 520.64 ± 79.80
K–W test, P = 0.984; Pc = 0.984
C/C: 63.46 ± 66.58
C/A: 58.17 ± 54.98
A/A: 43.02 ± 55.53
K–W test, P = 0.218; Pc = 0.400
GABRP rs1063310 C/A C/C: 473.42 ± 83.54
C/A: 454.85 ± 81.03
A/A: 466.97 ± 95.61
K–W test, P = 0.279; Pc = 0.528
C/C: 528.79 ± 98.44
C/A: 507.94 ± 88.97
A/A: 549.27 ± 93.39
K–W test, P = 0.206; Pc = 0.567
C/C: 55.36 ± 66.72
C/A: 53.09 ± 50.86
A/A: 82.30 ± 73.66
K–W test, P = 0.509; Pc = 0.676
GABRQ rs3810651 T/A T/T: 464.03 ± 83.22
T/A: 464.20 ± 85.38
A/A: 473.42 ± 97.88
K–W test, P = 0.967; Pc = 0.967
T/T: 519.73 ± 95.53
T/A: 522.95 ± 93.95
A/A: 536.18 ± 105.68
K–W test, P = 0.823; Pc = 0.984
T/T: 55.70 ± 59.80
T/A: 58.75 ± 58.34
A/A: 62.76 ± 67.87
K–W test, P = 0.673; Pc = 0.740
GABRR1 rs12200969 T/C T/T: 462.98 ± 84.27
T/C: 460.58 ± 82.61
C/C: 502.80 ± 105.46
K–W test, P = 0.065; Pc = 0.358
T/T: 530.10 ± 89.71
T/C: 506.08 ± 93.36
C/C: 555.30 ± 128.96
K–W test, P = 0.092; Pc = 0.337
T/T: 67.12 ± 61.10
T/C: 45.50 ± 59.04
C/C: 52.50 ± 68.94
K–W test, P = 0.017; Pc = 0.094
GABRR1 rs1186902 T/C T/T: 466.26 ± 84.26
T/C: 449.31 ± 73.92
C/C: –
K–W test, P = 0.288; Pc= 0.528
T/T: 522.82 ± 91.97
T/C: 516.29 ± 108.69
C/C: –
K–W test, P = 0.337; Pc = 0.617
T/T: 56.56 ± 57.96
T/C: 66.97 ± 91.77
C/C: –
K–W test, P = 0.804; Pc = 0.804
GABRR2 rs282129 G/A G/G: 466.32 ± 91.05
G/A: 457.10 ± 69.47
A/A: 501.36 ± 101.12
K–W test, P =0.394; Pc = 0.542
G/G: 529.01 ± 100.32
G/A: 506.82 ± 83.62
A/A: 541.37 ± 95.93
K–W test, P = 0.259; Pc = 0.570
G/G: 62.69 ± 62.44
G/A: 49.72 ± 53.77
A/A: 40.01 ± 35.49
K–W test, P = 0.080; Pc = 0.223
GABRR3 rs832032 A/T A/A: 457.68 ± 81.01
A/T: 474.20 ± 94.08
T/T: 504.58 ± 105.39
K–W test, P = 0.254; Pc = 0.528
A/A: 510.15 ± 92.12
A/T: 542.26 ± 99.86
T/T: 542.50 ± 119.18
K–W test, P = 0.064; Pc = 0.337
A/A: 52.47 ± 51.43
A/T: 68.05 ± 71.79
T/T: 37.91 ± 73.90
K–W test, P = 0.303, Pc = 0.476
Kruskal–Wallis Test (K–W) was used because none of the reaction times, nor the differences, followed a normal distribution. Crude P-values are adjusted by sex. Pc-values correspond
to the corrected P values calculated according to the FDR procedure.
gene: P = 0.031, P < 0.001 and P = 0.001 for basal, peak
and the difference in reaction time, respectively. This implies
that individuals with GABRA4 receptors with a leucine in
position 26 react faster, and are less sensitive to ethanol, as
compared with individuals that have a methionine instead. The
percentage of variation of the basal functional response was 14.97
± 15.23 for individuals with the G/G genotype, 14.07 ± 13.04
for individuals with the G/T genotype, and 6.51 ± 14.34 for
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individuals with the T/T genotype (K–W test P= 0.005). Another
significant effect was observed in the difference in the reaction
time for individuals with GABRR1 rs12200969 C/C genotype
(crude P = 0.017; Table 3). The percentage of variation of the
basal functional response was 15.60 ± 14.91 for individuals
with the T/T genotype, 10.49 ± 13.14 for individuals with the
T/C genotype, and 10.92 ± 14.20 for individuals with the C/C
genotype (K–W test P = 0.017). However, in this case the
TABLE 4 | Distribution of motor times according GABR genotypes.
Basal motor time (Ms) ± SD Motor time at ethanol Peak (Ms) ± SD Difference (Ms) ± SD
GABRA4 rs2229940 G/T G/G: 172.13 ± 59.74
G/T: 164.40 ± 60.13
T/T: 158.91 ± 43.80
K–W test, P =0.470; Pc = 0.932
G/G: 185.17 ± 60.64
G/T: 173.12 ± 60.30
T/T: 173.17 ± 43.80
K–W test, P = 0.302; Pc = 0.977
G/G: 13.04 ± 31.79
G/T: 8.72 ± 31.73
T/T: 14.26 ± 25.37
K–W test, P = 0.672; Pc = 0.905
GABRA6 rs4454083 T/C T/T: 169.52 ± 50.29
T/C: 177.92 ± 67.37
C/C: 135.66 ± 36.81
K–W test, P = 0.003; Pc = 0.033
T/T: 181.70 ± 54.21
T/C: 186.92 ± 66.22
C/C: 146.65 ± 48.99
K–W test, P = 0.003; Pc = 0.033
T/T: 12.18 ± 31.66
T/C: 9.00 ± 32.36
C/C: 10.99 ± 28.80
K–W test, P = 0.691; Pc = 0.905
GABRB3 rs12910925 C/T C/C: 165.12 ± 53.17
C/T: 171.35 ± 63.24
T/T: 161.88 ± 50.04
K–W test, P = 0.893; Pc = 0.932
C/C: 177.55 ± 50.89
C/T: 182.42 ± 65.62
T/T: 174.86 ± 54.69
K–W test, P = 0.894; Pc = 0.977
C/C: 12.44 ± 34.94
C/T: 11.08 ± 33.44
T/T: 12.99 ± 21.68
K–W test, P = 0.797; Pc = 0.905
GABRG2 rs211035 G/A G/G: 169.11 ± 60.74
G/A: 164.07 ± 49.55
A/A: 199.11 ± 70.13
K–W test, P = 0.364; Pc = 0.932
G/G: 177.84 ± 58.73
G/A: 181.62 ± 61.96
A/A: 210.28 ± 86.14
K–W test, P = 0.382; Pc = 0.977
G/G: 8.73 ± 33.15
G/A: 17.55 ± 28.20
A/A: 15.33 ± 8.06
K–W test, P = 0.273; Pc = 0.905
GABRR3 rs832032 A/T A/A: 163.58 ± 55.78
A/T: 171.03 ± 62.07
T/T: 158.27 ± 45.46
K–W test, P = 0.910; Pc = 0.932
A/A: 177.02 ± 59.78
A/T: 177.69 ± 56.19
T/T: 173.20 ± 52.08
K–W test, P = 0.976; Pc = 0.977
A/A: 13.44 ± 32.53
A/T: 6.66 ± 28.86
T/T: 14.93 ± 15.14
K–W test, P = 0.484; Pc = 0.905
GABRP rs1063310 C/A C/C: 168.35 ± 58.56
C/A: 166.23 ± 58.01
A/A: 155.46 ± 45.59
K–W test, P = 0.932; Pc = 0.932
C/C: 180.63 ± 62.54
C/A: 176.08 ± 54.86
A/A: 165.20 ± 53.97
K–W test, P = 0.900; Pc = 0.977
C/C: 12.28 ± 30.56
C/A: 9.85 ± 35.09
A/A: 9.74 ± 18.46
K–W test, P = 0.871; Pc = 0.905
GABRQ rs3810651 T/A T/T: 169.20 ± 62.59
T/A: 165.28 ± 58.32
A/A: 160.29 ± 45.94
K–W test, P = 0.900; Pc = 0.932
T/T: 177.12 ± 54.96
T/A: 177.90 ± 65.43
A/A: 174.23 ± 53.61
K–W test, P = 0.977; Pc = 0.977
T/T: 7.93 ± 33.41
T/A: 12.63 ± 25.53
A/A: 13.96 ± 33.54
K–W test, P = 0.905; Pc = 0.905
GABRR1 rs12200969 T/C T/T: 165.61 ± 50.89
T/C: 164.33 ± 62.72
C/C: 177.77 ± 73.74
K–W test, P = 0.647; Pc = 0.932
T/T: 176.91 ± 56.48
T/C: 175.23 ± 63.07
C/C: 181.64 ± 54.43
K–W test, P = 0.805; Pc = 0.977
T/T: 11.31 ± 26.84
T/C: 10.90 ± 31.21
C/C: 3.86 ± 44.03
K–W test, P = 0.547; Pc = 0.905
GABRR1 rs1186902 T/C T/T: 167.07 ± 58.23
T/C: 161.16 ± 52.71
C/C: –
K–W test, P = 0.595; Pc = 0.932
T/T: 177.82 ± 58.83
T/C: 172.95 ± 54.89
C/C: –
K–W test, P = 0.624; Pc = 0.977
T/T: 10.75 ± 32.02
T/C: 11.79 ± 24.93
C/C: –
K–W test, P = 0.903; Pc = 0.905
GABRR2 rs282129 G/A G/G: 163.90 ± 51.66
G/A: 172.28 ± 70.29
A/A: 170.10 ± 60.50
K–W test, P =0.896; Pc = 0.932
G/G: 174.78 ± 54.03
G/A: 183.73 ± 67.54
A/A: 188.50 ± 89.55
K–W test, P = 0.869; Pc = 0.977
G/G: 10.89 ± 30.55
G/A: 11.45 ± 33.47
A/A: 18.40 ± 36.34
K–W test, P = 0.899; Pc = 0.905
GABRE rs1139916 C/A C/C: 159.30 ± 47.89
C/A: 176.77 ± 74.11
A/A: 166.65 ± 49.47
K–W test, P = 0.371; Pc = 0.932
C/C: 172.58 ± 52.46
C/A: 184.80 ± 73.69
A/A: 175.25 ± 43.84
K–W test, P = 0.891; Pc = 0.977
C/C: 13.28 ± 29.15
C/A: 8.03 ± 28.85
A/A: 8.60 ± 37.49
K–W test, P = 0.709; Pc = 0.905
Kruskal–Wallis Test (K–W) was used because none of the reaction times, nor the differences, followed a normal distribution. Crude P-values are adjusted by sex. Pc-values correspond
to the corrected P values calculated according to the FDR procedure.
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K–W test did not remain significant after correction for multiple
comparisons, and nor did the T-test when individuals were
compared with the rs12200969 C/C genotype with individuals
carrying at least one non-mutated gene: P = 0.068.
Table 4 shows the distribution of the motor times according
to GABR genotypes. Basal motor time and peak motor time were
shorter among individuals carrying the GABRA6 rs4454083 C/C
genotype, as compared with individuals carrying at least one non-
mutated gene. The K–W test remains significant for both motor
times after correction for multiple comparisons. In addition, the
T-test reveals very significant differences when individuals with
the rs2229940 T/T genotype were compared, with individuals
carrying at least one non-mutated gene: P < 0.001 and P = 0.001
for basal and peak motor time, respectively. This implies that
individuals with GABRA6 receptors with a proline in the
position 13 instead of leucine have faster motor times. In
contrast, no statistically significant effects related to ethanol
(that is, the difference between basal motor time minus peak
motor time) were observed. The percentage of variation of
the basal functional response was 8.38 ± 17.15 for individuals
with the T/T genotype, 6.84 ± 17.94 for individuals with the
T/C genotype, and 8.99 ± 23.56 for individuals with the C/C
genotype (K–W test P = 0.746). No other associations with
motor times were identified when other GABR genotypes were
analyzed.
Table 5 shows the haplotype analysis results for the whole
study group. Due to the high frequency of variant GABR alleles,
no common haplotypes were observed. The most common
haplotype had a frequency of about 6%, and rare haplotypes
(with frequencies lower than 1%) accounted for almost 50% of
all haplotypes identified. For that reason, and in order to refine
the putative genetic associations, the effect of inferred haplotypes
on reaction and motor times was studied for the SNPs that
displayed any association in Tables 3, 4, the SNPs associated to
the most common GABA-A receptor configuration and the SNPs
associated to the subunit combinations that are themost sensitive
to ethanol. Table 6 shows the association of haplotypes, adjusted
by sex, with reaction and motor times. Several statistically
significant associations were identified, even after FDR correction
for multiple comparisons. However, some haplotypes caused
modest changes in reaction or motor times. In addition, some
haplotypes that caused larger changes are extremely rare. Table 6
was sorted by type of effect, then statistical significance and
then effect intensity. Only two particular effects corresponded
unambiguously to specific variant haplotype distributions, as
compared to the reference haplotype GTCGT. These are the
haplotype GCTGC (corresponding to variant alleles in GABRA6
and GABRB3), which is related to slower basal movement time,
and the haplotype TTTAC (corresponding to variant alleles in
GABRA4, GABRB3, GABRG2, and GABRR1), which is related to

























1 G T T G C C T T T G A 0.0641
2 G T C G C C A T T G A 0.0503
3 G T C G A C T T T G A 0.0406
4 T T C G C C T T T G A 0.0358
5 T T T G C C T T T G A 0.0240
6 G T T G A C A T T G A 0.0224
7 T T T G A C T T T G A 0.0223
8 G C T G C C A T T G A 0.0201
9 G C C G A C A T T G A 0.0197
10 G T C G C C T T T G A 0.0197
11 G T C G C C T C T G A 0.0172
12 G T C G C A T T T G A 0.0159
13 G C T G C C T C T A A 0.0156
14 G T C G C C A C T G A 0.0150
15 G C C G A C T T T G A 0.0145
16 G T T G C C A T T G A 0.0141
17 T T T G C A A T T G A 0.0138
18 G T C G A C A T T G A 0.0138
19 T C T A C A A T T G A 0.0129
20 G T T G C C T C T G A 0.0126
21 T T C G A C A C T A A 0.0118
22 G T T G C C A T T A A 0.0116
23 T C T G C A T T T G T 0.0114
Rare
haplotypes
– – – – – – – – – – – 0.4691
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Difference Ms (95% CI) P-value Pc
Reference haplotype G T C G T 0.1483 0.00 – –
Basal RT: Faster G T C G C 0.0100 −69.94 (−72.71 to −67.17) <0.0001 0.0002
Basal RT: Faster G C C A T 0.0149 −63.08 (−65.92 to −60.23) <0.0001 0.0002
Basal RT: Faster T T C A T 0.0171 −25.09 (−28.38 to −21.8) <0.0001 0.0002
Basal RT: Faster T C T A T 0.0231 −21.74 (−31.04 to −12.43) <0.0001 0.0002
Basal RT: Faster G T T A T 0.0230 −19.38 (−25.63 to −13.14) <0.0001 0.0002
Basal RT: Slower T T T A T 0.0131 202.36 (200.22 to 204.49) <0.0001 0.0002
Basal RT: Slower G T C A T 0.0156 42.96 (39.25 to 46.66) <0.0001 0.0002
Peak RT: Faster T T T G C 0.0241 −29.39 (−40.4 to −18.37) <0.0001 0.0004
Peak RT: Faster T C C A T 0.0212 −24.59 (−39.19 to −9.99) 0.0009 0.0027
Peak RT: Faster T C T G T 0.0267 −28.71 (−46.27 to −11.14) 0.0014 0.0033
Peak RT: Faster G C T A T 0.0197 −10.61 (−19.95 to −1.27) 0.0260 0.0494
Peak RT: Slower T C T A T 0.0070 249.37 (246.13 to 252.6) <0.0001 0.0004
Peak RT: Slower T C C G C 0.0086 156.56 (153.04 to 160.07) <0.0001 0.0004
Peak RT: Slower G C T G C 0.0230 145.03 (139.91 to 150.15) <0.0001 0.0004
Peak RT: Slower T T T A C 0.0091 121.38 (116.19 to 126.56) <0.0001 0.0004
Peak RT: Slower G T T A T 0.0390 68.55 (28.02 to 109.08) 0.0009 0.0027
Peak RT: Slower G C T G T 0.0496 53.65 (14.27 to 93.03) 0.0076 0.0160
Peak RT: Slower T T C G C 0.0390 13.18 (0.3 to 26.06) 0.0450 0.0777
Difference RT: Lower T T T G C 0.0187 −32.22 (−57.64 to −6.81) 0.0130 0.0867
Difference RT: Larger T C T A T 0.0035 103.36 (100.3 to 106.41) <0.0001 0.0010
Difference RT: Larger T C C G C 0.0166 53.79 (45.97 to 61.6) <0.0001 0.0010
Difference RT: Larger G T T A T 0.0371 37.66 (0.74 to 74.57) 0.0460 0.2300
Basal MT: Slower G C T G C 0.0070 165.46 (113.85 to 217.06) <0.0001 0.0010
Basal MT: Faster T T T A C 0.0096 −45.78 (−55.07 to −36.5) <0.0001 0.0010
Basal MT: Faster T T C G T 0.0853 −26.89 (−46.84 to −6.95) 0.0083 0.0553
Basal MT: Faster T C T G T 0.0403 −36.03 (−65.98 to −6.09) 0.0180 0.0900
Peak MT: Slower G T C A T 0.0071 141.91 (126.42 to 157.39) <0.0001 0.0010
Peak MT: Slower G C T G C 0.0235 66.54 (29.82 to 103.27) 0.0004 0.0026
Peak MT: Faster T T T A C 0.0090 −42.88 (−53.57 to −32.19) <0.0001 0.0010
Difference MT: Lower G C T G T 0.0382 −25.16 (−43.17 to −7.15) 0.0062 0.1240
Associations were sorted by effect, then statistical significance and then intensity of the effect. RT; reaction time; MT, motor time. P-values were adjusted by sex. Pc-values correspond
to the corrected P values calculated according to the FDR procedure.
faster peak movement time. These two haplotypes, however, are
extremely rare.
DISCUSSION
Genetic variation in GABR genes has been related to ethanol
effects in animal models, with controversial findings (Hanchar
et al., 2004; Wallner et al., 2006; Borghese and Harris, 2007;
Botta et al., 2007; Jia et al., 2007; Korpi et al., 2007; Lovinger
and Homanics, 2007; Mody et al., 2007; Olsen et al., 2007;
Santhakumar et al., 2007). This study analyzes for the first time
the effect of common human GABR missense polymorphisms
in reaction time, motor time and low-dose ethanol effects
in vivo. Human GABR genes showed a modest inter-individual
variability as compared to other genes. No common missense
or stop polymorphisms have been described for GABRA1, 2,
3, and 5. In contrast, the genes GABRA4 and GABRA6 have
one common missense polymorphism each. These genes encode
subunits that have been reported to be related to low-dose ethanol
effects (Hanchar et al., 2004; Wallner et al., 2006; Lovinger and
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Homanics, 2007) and, indeed, one of these polymorphisms is
associated in this study to inter-individual differences in reaction
times and in ethanol effects (GABRA4 rs2229940), whereas
the other one is related to inter-individual differences in the
motor times (GABRA6 rs4454083) although not to ethanol
effects. In both cases, variant subunits are associated with faster
times, which is consistent with a functional impairment in
inhibitory receptors, such as GABA-A receptors. The amino acid
substitution caused by the GABRA4 polymorphism rs2229940
is predicted as deleterious by using SIFT and as benign by
using PolyPhen, and it was reported to display a marginal
association with nicotine dependence (Agrawal et al., 2008,
2009). Predictions for the GABRA6 polymorphism are also
deleterious with SIFT, with low confidence, possibly damaging
with PolyPhen, but no clinical associations have been yet
described.
Besides GABRα4 and GABRα6, the GABA-A subunit
combinations containing GABRβ3 and GABRδ are in the model
proposed by Hanchar et al. as the primary targets for ethanol
(Hanchar et al., 2004). GABRB3 has two common missense
polymorphisms (Table 1) that are at complete linkage, and that
in the present study are not associated to reaction times, motor
times or ethanol effects (Tables 3, 4). As forGABRD, no common
missense SNPs have been described (Table 1). Hence, among
ethanol-sensitive subunit combinations, the strongest candidates
to play a role in the genetic variability of ethanol effects are
GABRα4 and GABRα6.
The rest of the common missense GABR gene variations
did not show in this study a major association with reaction
times, motor times, or ethanol effects (Tables 3, 4). Regarding
the putative clinical associations for these polymorphisms, the
GABRG2 SNP designated as rs211035 was previously investigated
in relation to epilepsy with negative results (Dixit et al., 2016). It
has been proposed that the GABRE SNP designated as rs1139916
affects the binding of extracellular ligands, and it has been
associated with migraine risk in women, with carriers of variant
alleles being at decreased risk (Quintas et al., 2013). Our own
findings confirm this observation (García-Martín et al., 2018).
In addition, a weak association of this SNP with some types
of breast cancer has been identified in an exome sequencing
study (Li et al., 2015). The GABRP rs1063310 SNP has been
analyzed as a putative predisposing factor for autism, although
no significant association was identified (Ma et al., 2005).
Association of the GABRQ SNP rs3810651 with response to
antidepressants has been claimed in a single study carried out
on Chinese individuals (Pu et al., 2013). This SNP has also
been analyzed as a putative risk factor for essential tremor,
with negative findings (Garcia-Martin et al., 2011a). A putative
association of heterozygosity (T/A genotype) with increased
risk of developing migraine has been described (Quintas et al.,
2013), although these findings could not be replicated by our
group (García-Martín et al., 2018). GABRR1 SNPs rs1186902
and rs12200969 were analyzed as putative risk factors related to
ethanol dependence, but no association was identified (Xuei et al.,
2010). Conversely, the GABRR2 SNP rs282129 was significantly
related to ethanol dependence (Xuei et al., 2010), and recently
it has been claimed to be related to cognitive ability (Ma et al.,
2017).
In summary, we identified for the first time functional
consequences in vivo of two common missense GABR
polymorphisms. These concern the subunits GABRα4 and
GABRα6, which have been reported to be part of sensitive
subunit combinations to ethanol. It could be speculated that
GABA-A receptors containing such subunits could possibly
cause selective changes in reaction and motor time, respectively,
by being expressed in different brain regions. Interesting findings
regarding a differential effect of extrasynaptic and synaptic
GABA inhibition with similar GABA concentrations have been
reported (Mooney et al., 2017), and these findings raise evidences
supporting effects related to receptor location. The findings
regarding the effect of these polymorphisms on reaction times
and movement times may have additional clinical implications
in movement disorders: Patients with essential tremor and
Parkinson’s disease have slower reaction times and/or motor
times as compared to healthy subjects (Montgomery et al., 2000;
Jimenez-Jimenez et al., 2010). In patients with restless syndrome
motor impairment exists too, although it is restricted to some
movements (Jimenez-Jimenez et al., 2009). GABR alteration may
be related to the clinical presentation of movement disorders: for
instance, increased expression of GABRα4 has been described
in tremor rats (Mao et al., 2011), and our own findings suggest
that the GABRA4 rs2229940 T/T genotype is related to younger
age at onset of restless legs syndrome (Jiménez-Jiménez et al.
submitted). In the light of the findings obtained in the present
study, it would be interesting to verify in further studies
whether the GABRA4 rs2229940 and the GABRA6 rs4454083
polymorphisms, isolated or combined, are related to clinical
presentation, and particularly to severity, reaction time or motor
impairment, in patients suffering from movement disorders.
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